In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report), with a price ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker (SYK – Research Report) yesterday and set a price target of $394.00. The ...

BTIG Research has recently reduced Beyond Air Inc (XAIR) stock to Neutral rating, as announced on June 25, 2024, according to Finviz. Earlier, on July 28, 2023, Piper Sandler had initiated the stock ...

BTIG Research has recently reduced Fiverr International Ltd (FVRR) stock to Neutral rating, as announced on November 4, 2024, according to Finviz. Earlier, on July 2, 2024, UBS had reduced the stock ...

Fintel reports that on January 7, 2025, BTIG initiated coverage of Hims & Hers Health (NYSE:HIMS) with a Buy recommendation.

BTIG analyst Thomas Shrader lowered the firm’s price target on Denali Therapeutics (DNLI) to $32 from $35 and keeps a Buy rating on the shares after the company announced topline data from the Phase 2 ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report) has earned a consensus recommendation of “Hold” from the twenty ...

Director Kaufman 2012 Descendants Trust sold 7,500 shares of the stock in a transaction dated Thursday, January 2nd. The ...

Short seller Hindenburg Research accused Carvana of accounting manipulation and unstable loans. The company denies the ...

The report centers on Carvana’s practice of loan sales as well as the business relationship between CEO Ernie Garcia III and ...